Corticosteroids as Co-Induction Agents With Vedolizumab in Crohn's Disease: a Double-blind Placebo Controlled Randomized Trial
Phase of Trial: Phase IV
Latest Information Update: 21 Jun 2017
At a glance
- Drugs Prednisone (Primary) ; Vedolizumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 13 Jun 2017 Planned End Date changed from 1 Mar 2017 to 1 Jun 2018.
- 13 Jun 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jun 2018.
- 10 Jun 2017 Biomarkers information updated